Dwayne L. Lashyn
Direktor/Vorstandsmitglied bei Ethicann Pharmaceuticals, Inc.
Profil
Dwayne L.
Lashyn is currently working as the Managing Director & Vice President at Quantico Capital Corp.
and as a Director at Ethicann Pharmaceuticals, Inc. He previously worked as an Independent Director at CanniMed Therapeutics, Inc. from 2004 to 2018.
Aktive Positionen von Dwayne L. Lashyn
Unternehmen | Position | Beginn |
---|---|---|
Quantico Capital Corp. | Corporate Officer/Principal | 01.06.1992 |
Ethicann Pharmaceuticals, Inc.
Ethicann Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethicann Pharmaceuticals, Inc. manufactures pharmaceutical products. It focuses on the commercialization of cannabis-based ethical drugs. The company was founded by Brandon J. Price in 2018 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Dwayne L. Lashyn
Unternehmen | Position | Ende |
---|---|---|
CANNIMED THERAPEUTICS INC | Direktor/Vorstandsmitglied | 15.03.2018 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Quantico Capital Corp. | |
CanniMed Therapeutics, Inc.
CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada. | Health Technology |
Ethicann Pharmaceuticals, Inc.
Ethicann Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ethicann Pharmaceuticals, Inc. manufactures pharmaceutical products. It focuses on the commercialization of cannabis-based ethical drugs. The company was founded by Brandon J. Price in 2018 and is headquartered in Toronto, Canada. | Health Technology |